Crane Biosciences
Focus: Crane Biosciences is a UK-based gene therapy company focused on oncology, currently operating with minimal public footprint and early-stage clinical programs. The company is pre-revenue and appears to be in early development phases with limited scale.
Profile data last refreshed 11h ago · AI intelligence enriched 2w ago
Open Jobs
0
About Crane Biosciences
AI assessmentNot HiringNo open roles listed right now. Follow Crane Biosciences to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
2 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Longitudinal Study of the Default-mode Network Connectivity in Brain Injured Patients Recovering Fro
ComaClinical Trials (1)
NCT01620957Longitudinal Study of the Default-mode Network Connectivity in Brain Injured Patients Recovering From Coma
N/AHelp build intelligence for Crane Biosciences
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.